Annual Gross Margin
96.62%
-0.06%-0.06%
31 December 2023
Summary:
Karyopharm Therapeutics annual gross profit margin is currently 96.62%, with the most recent change of -0.06% (-0.06%) on 31 December 2023. During the last 3 years, it has fallen by -1.76% (-1.79%). KPTI annual gross margin is now -1.79% below its all-time high of 98.38%, reached on 31 December 2021.KPTI Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
96.65%
+0.07%+0.07%
30 September 2024
Summary:
Karyopharm Therapeutics quarterly gross profit margin is currently 96.65%, with the most recent change of +0.07% (+0.07%) on 30 September 2024. Over the past year, it has increased by +1.05% (+1.10%). KPTI quarterly gross margin is now -2.78% below its all-time high of 99.41%, reached on 31 December 2021.KPTI Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KPTI Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +1.1% |
| 3 y3 years | -1.8% | -2.8% |
| 5 y5 years | +2.7% | +4.7% |
KPTI Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.8% | at low | -2.8% | +2.6% |
| 5 y | 5 years | -1.8% | +2.7% | -2.8% | +4.7% |
| alltime | all time | -1.8% | +2.7% | -2.8% | +4.7% |
Karyopharm Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 96.65%(+0.1%) |
| June 2024 | - | 96.58%(+2.5%) |
| Mar 2024 | - | 94.23%(-1.4%) |
| Dec 2023 | 96.62%(-0.1%) | 95.60%(-1.9%) |
| Sept 2023 | - | 97.47%(+0.7%) |
| June 2023 | - | 96.82%(+0.3%) |
| Mar 2023 | - | 96.51%(+2.2%) |
| Dec 2022 | 96.68% | 94.44%(-2.9%) |
| Sept 2022 | - | 97.29%(-0.3%) |
| June 2022 | - | 97.63%(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 97.01%(-2.4%) |
| Dec 2021 | 98.38%(+0.9%) | 99.41%(+1.0%) |
| Sept 2021 | - | 98.44%(+3.7%) |
| June 2021 | - | 94.96%(-1.1%) |
| Mar 2021 | - | 95.99%(-1.0%) |
| Dec 2020 | 97.50%(+3.6%) | 97.00%(-1.0%) |
| Sept 2020 | - | 97.95%(-0.9%) |
| June 2020 | - | 98.82%(+3.5%) |
| Mar 2020 | - | 95.48%(+3.4%) |
| Dec 2019 | 94.11% | 92.30%(0.0%) |
| Sept 2019 | - | 92.30% |
FAQ
- What is Karyopharm Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly gross margin year-on-year change?
What is Karyopharm Therapeutics annual gross profit margin?
The current annual gross margin of KPTI is 96.62%
What is the all time high annual gross margin for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual gross profit margin is 98.38%
What is Karyopharm Therapeutics quarterly gross profit margin?
The current quarterly gross margin of KPTI is 96.65%
What is the all time high quarterly gross margin for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly gross profit margin is 99.41%
What is Karyopharm Therapeutics quarterly gross margin year-on-year change?
Over the past year, KPTI quarterly gross profit margin has changed by +1.05% (+1.10%)